High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer

(2009) E Korkeila et al.   BRITISH JOURNAL OF CANCER

Carbonic anhydrase IX in bladder cancer

(2009) Tobias Klatte et al.   CANCER

Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas

(2009) Tetsukan Woo et al.   LUNG CANCER

Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract

(2009) L. HYRSL et al.   NEOPLASMA

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status

(2008) P Hofman et al.   BRITISH JOURNAL OF CANCER

Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH

(2008) J. Chiche et al.   CANCER RESEARCH

Tissue microarrays: emerging standard for biomarker validation

(2008) Saima Hassan et al.   CURRENT OPINION IN BIOTECHNOLOGY

Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma

(2008) Sung-Weon Choi et al.   HUMAN PATHOLOGY

Overexpression of Intrinsic Hypoxia Markers HIF1α and CA-IX Predict for Local Recurrence in Stage T1-T2 Glottic Laryngeal Carcinoma Treated With Radiotherapy

(2008) M.L. Schrijvers et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes

(2008) Mika Hilvo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Serum Carbonic Anhydrase 9 Level is Associated With Postoperative Recurrence of Conventional Renal Cell Cancer

(2008) Guorong Li et al.   JOURNAL OF UROLOGY

Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer

(2008) Francesca Malentacchi et al.   LUNG CANCER

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

(2008) Claudiu T. Supuran   NATURE REVIEWS DRUG DISCOVERY